Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keystonemab
Utrecht, Utrecht Province, Netherlandskeystonemab.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Keystonemab has developed an AI-driven SaaS platform that analyzes millions of scientific articles, patents, clinical trial publications, genomic/proteomic/transcriptomic data to identify new uses for existing drugs (repositioning), synergistic drug combinations, and novel targets. The company completed its initial platform development in July 2020. As of late 2020–2021 it was running pilot projects with biopharma partners to validate model predictions but had not yet advanced proprietary therapeutics into clinical trials[3]. No direct clinical results are reported.
- Therapeutic areas
- OncologyRare DiseasesImmunology
- Modalities
- Small molecule (via drug repositioning and combinations)Biologic
- Industry
- Drug Discovery Services
02
Partnerships
Emona Biopharma d.o.o. (co-development of high-value generics using the AI platform)
Beyond the preview
Go deeper on Keystonemab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keystonemab.